Financial Snapshot

This section of the Fusion Pharmaceuticals InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Fusion Pharmaceuticals assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQFUSN
Beta0.04
Shares Outstanding42.4M
Average Volume (10 days)67.9K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($19.00)
Sales (TTM)$0.00
Book Value (MRQ)$6.94
Cash Flow (TTM)($1.35)
Cash (MRQ)$5.33

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy4
 
Buy1
 
Hold0
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Heather Preston
Director
8,823
Buy
Jun 30, 2020
Chau Q. Khuong
Director
705,900
Buy
Jun 30, 2020
Chau Q. Khuong
Director
192,100
Buy
Jun 30, 2020
Johan Christenson
Director
240,000
Buy
Jun 30, 2020
Heather Preston
8,823
Buy
Jun 30, 2020

Recent SEC Filings

Company Events
Apr 2, 2021
Company Events
Apr 2, 2021
Insider Buy/Sell
Apr 1, 2021
New Insider
Apr 1, 2021
SEC STAFF LETTER
Mar 29, 2021
NEVER MISS AN UPDATE